Viewing Study NCT00003058


Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2025-12-25 @ 10:14 PM
Study NCT ID: NCT00003058
Status: COMPLETED
Last Update Posted: 2017-02-13
First Post: 1999-11-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Troglitazone in Treating Patients With Liposarcoma
Sponsor: Dana-Farber Cancer Institute
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 1997-06
Start Date Type: None
Primary Completion Date: 2000-01
Primary Completion Date Type: ACTUAL
Completion Date: 2000-01
Completion Date Type: ACTUAL
First Submit Date: 1999-11-01
First Submit QC Date: None
Study First Post Date: 2004-08-12
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-02-09
Last Update Post Date: 2017-02-13
Last Update Post Date Type: ACTUAL